Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Terry Fry

Concepts (466)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunotherapy, Adoptive
42
2026
337
9.810
Why?
T-Lymphocytes
60
2026
1982
6.420
Why?
Antigens, CD19
27
2026
129
4.590
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
16
2026
89
4.390
Why?
Graft vs Host Disease
20
2023
264
3.430
Why?
Sialic Acid Binding Ig-like Lectin 2
13
2026
21
3.300
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
2025
293
3.160
Why?
CD8-Positive T-Lymphocytes
19
2025
917
2.900
Why?
Hematopoietic Stem Cell Transplantation
26
2023
675
2.830
Why?
Receptors, Antigen, T-Cell
18
2023
668
2.770
Why?
Immunotherapy
16
2024
653
2.540
Why?
Interleukin-7
23
2012
65
2.320
Why?
Dendritic Cells
12
2026
499
2.320
Why?
CD4-Positive T-Lymphocytes
12
2026
1129
1.870
Why?
Cancer Vaccines
9
2018
160
1.840
Why?
Hematologic Neoplasms
8
2023
161
1.680
Why?
Leukemia, Myeloid, Acute
6
2025
682
1.660
Why?
Lymphoma, B-Cell
8
2025
132
1.590
Why?
Bone Marrow Transplantation
9
2023
294
1.220
Why?
Lymphocyte Transfusion
4
2017
20
1.190
Why?
Adoptive Transfer
10
2019
198
1.120
Why?
Graft vs Leukemia Effect
4
2017
12
0.960
Why?
Mice
46
2026
18339
0.950
Why?
Cytokines
12
2022
2061
0.910
Why?
Animals
62
2026
38058
0.890
Why?
Dipeptides
3
2014
57
0.880
Why?
Antigens, Neoplasm
5
2019
271
0.880
Why?
H-Y Antigen
5
2013
11
0.870
Why?
T-Box Domain Proteins
1
2025
106
0.850
Why?
Neoplasms
13
2023
2875
0.830
Why?
Cell Line, Tumor
16
2025
3540
0.810
Why?
Graft vs Tumor Effect
3
2021
8
0.790
Why?
Humans
115
2026
144759
0.720
Why?
Tumor Escape
3
2021
49
0.700
Why?
Sialic Acid Binding Ig-like Lectin 3
1
2021
10
0.700
Why?
Cell Adhesion Molecules
1
2022
178
0.680
Why?
Immune System
5
2010
179
0.670
Why?
Receptors, Cytokine
2
2024
36
0.670
Why?
Perforin
1
2020
21
0.660
Why?
Precursor Cells, B-Lymphoid
2
2018
41
0.660
Why?
Leukemia
5
2025
245
0.650
Why?
Thymus Gland
6
2004
311
0.650
Why?
Retinal Neoplasms
1
2020
37
0.640
Why?
Retinoblastoma
1
2020
42
0.640
Why?
WT1 Proteins
2
2018
12
0.640
Why?
Xenograft Model Antitumor Assays
8
2025
928
0.620
Why?
Recurrence
13
2025
1135
0.600
Why?
Myelodysplastic Syndromes
5
2023
147
0.600
Why?
Lymphoma
2
2019
232
0.600
Why?
T-Lymphocyte Subsets
6
2023
415
0.600
Why?
Transplantation, Homologous
9
2018
415
0.600
Why?
Adjuvants, Immunologic
4
2014
245
0.590
Why?
Erythropoietin
1
2020
100
0.580
Why?
Allergy and Immunology
1
2019
42
0.580
Why?
Neoplasms, Experimental
2
2019
173
0.580
Why?
Mice, Inbred C57BL
17
2021
5992
0.520
Why?
Genetic Engineering
2
2019
93
0.500
Why?
Child
36
2026
22633
0.500
Why?
Boron Compounds
2
2014
29
0.500
Why?
Calcitonin
1
2016
27
0.500
Why?
Hematopoietic Stem Cells
4
2016
420
0.490
Why?
Immunologic Memory
8
2025
366
0.490
Why?
Cell Lineage
2
2016
376
0.480
Why?
Disease Models, Animal
8
2026
4557
0.470
Why?
Cell Plasticity
1
2016
37
0.470
Why?
Lymphocyte Activation
11
2021
1126
0.470
Why?
Leukapheresis
2
2017
27
0.460
Why?
Antigens, CD
2
2017
555
0.450
Why?
Mice, Knockout
8
2026
3121
0.450
Why?
Donor Selection
1
2015
79
0.440
Why?
Apoptosis
8
2019
2430
0.430
Why?
STAT1 Transcription Factor
1
2014
68
0.420
Why?
Homeostasis
6
2006
640
0.420
Why?
Photopheresis
2
2011
9
0.420
Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2014
46
0.410
Why?
Rhabdomyosarcoma
2
2014
64
0.400
Why?
Signal Transduction
8
2025
5226
0.400
Why?
Receptors, G-Protein-Coupled
1
2015
233
0.400
Why?
Drug Resistance, Neoplasm
5
2024
881
0.390
Why?
Recombinant Fusion Proteins
4
2017
675
0.390
Why?
Vaccination
2
2012
1423
0.390
Why?
Boronic Acids
1
2013
37
0.380
Why?
Pore Forming Cytotoxic Proteins
1
2012
15
0.380
Why?
Lymphocyte Depletion
8
2014
132
0.380
Why?
Female
52
2026
78271
0.380
Why?
STAT3 Transcription Factor
1
2014
207
0.370
Why?
Young Adult
20
2026
14105
0.370
Why?
Neoplasm Proteins
1
2015
442
0.360
Why?
Adult
33
2026
40449
0.360
Why?
Flow Cytometry
6
2020
1173
0.360
Why?
Siblings
4
2014
195
0.360
Why?
Adolescent
26
2026
22428
0.350
Why?
Antigens, CD34
2
2011
88
0.350
Why?
Mice, Inbred C3H
4
2014
251
0.350
Why?
Neurotoxicity Syndromes
2
2024
38
0.340
Why?
Living Donors
3
2014
280
0.340
Why?
Lymphohistiocytosis, Hemophagocytic
2
2021
29
0.340
Why?
Protein Domains
2
2025
313
0.330
Why?
Neoplasm, Residual
3
2020
139
0.330
Why?
Antigen Presentation
2
2009
205
0.330
Why?
Neoplasm Metastasis
3
2016
688
0.320
Why?
Male
43
2026
72315
0.320
Why?
Receptors, Interleukin-7
5
2011
28
0.310
Why?
Transplantation Conditioning
4
2018
186
0.300
Why?
Lymphocyte Count
4
2017
164
0.300
Why?
Child, Preschool
17
2026
11787
0.300
Why?
Gene Expression
5
2020
1490
0.300
Why?
Urinary Bladder Neoplasms
2
2009
255
0.290
Why?
Interleukin-10
1
2011
309
0.290
Why?
Receptors, Interferon
1
2009
60
0.290
Why?
Sarcoma, Ewing
2
2012
102
0.280
Why?
Models, Immunological
4
2020
100
0.280
Why?
Mice, Transgenic
8
2026
2182
0.270
Why?
Monocytes
1
2011
538
0.270
Why?
Remission Induction
4
2017
307
0.270
Why?
Social Adjustment
1
2008
64
0.270
Why?
Clinical Trials as Topic
4
2019
1053
0.260
Why?
Mutation
2
2015
4089
0.260
Why?
Killer Cells, Natural
3
2021
467
0.260
Why?
Drug-Related Side Effects and Adverse Reactions
2
2020
257
0.260
Why?
Carcinoma
1
2009
228
0.250
Why?
Receptors, Antigen
2
2017
14
0.250
Why?
Gene Rearrangement
2
2024
155
0.240
Why?
Allografts
3
2018
150
0.240
Why?
Treatment Outcome
14
2026
11679
0.240
Why?
Lymphopoiesis
2
2006
27
0.240
Why?
Chemokine CCL3
1
2026
26
0.240
Why?
Neuroblastoma
2
2021
174
0.230
Why?
Interferon-gamma
1
2009
784
0.230
Why?
Prognosis
7
2020
4282
0.220
Why?
Macrophages
2
2026
1511
0.220
Why?
Unsupervised Machine Learning
1
2025
22
0.220
Why?
Immunocompromised Host
2
2010
201
0.220
Why?
Stem Cell Transplantation
1
2006
191
0.220
Why?
Philadelphia Chromosome
1
2024
18
0.220
Why?
Core Binding Factor Alpha 1 Subunit
1
2025
45
0.220
Why?
Unrelated Donors
3
2023
38
0.220
Why?
Disease Progression
5
2021
2847
0.220
Why?
Tissue Donors
4
2018
424
0.210
Why?
Neoplasm Recurrence, Local
3
2023
1137
0.210
Why?
Cytotoxicity, Immunologic
1
2025
223
0.210
Why?
Transplantation, Autologous
5
2018
290
0.210
Why?
HIV Infections
5
2008
3154
0.210
Why?
Berylliosis
1
2026
202
0.200
Why?
MAP Kinase Kinase Kinases
1
2024
70
0.200
Why?
Lentivirus
3
2019
60
0.200
Why?
T-Lymphocytes, Regulatory
4
2017
389
0.200
Why?
Peripheral Blood Stem Cell Transplantation
2
2014
35
0.200
Why?
Combined Modality Therapy
4
2021
1266
0.190
Why?
Interleukin-15
4
2014
97
0.190
Why?
Regeneration
2
2004
197
0.190
Why?
Protein Binding
3
2025
2273
0.190
Why?
fms-Like Tyrosine Kinase 3
1
2023
49
0.190
Why?
Genetic Vectors
3
2019
337
0.180
Why?
Mice, SCID
4
2019
369
0.180
Why?
Burkitt Lymphoma
1
2022
62
0.180
Why?
Antineoplastic Agents, Immunological
2
2021
199
0.180
Why?
Simian Acquired Immunodeficiency Syndrome
1
2002
92
0.180
Why?
Gangliosides
1
2021
23
0.170
Why?
Microglia
1
2024
268
0.170
Why?
Lymphopenia
4
2011
65
0.170
Why?
Thrombocytopenia
1
2023
205
0.170
Why?
Coculture Techniques
2
2012
246
0.170
Why?
Bone Marrow
3
2020
304
0.170
Why?
Capillary Leak Syndrome
1
2020
12
0.170
Why?
Exotoxins
1
2020
16
0.160
Why?
Macrophage Activation Syndrome
1
2020
22
0.160
Why?
Myeloid-Lymphoid Leukemia Protein
1
2021
72
0.160
Why?
Image Processing, Computer-Assisted
1
2025
780
0.160
Why?
Recovery of Function
1
2005
707
0.160
Why?
Immunotoxins
1
2020
55
0.160
Why?
Anxiety
1
2008
1109
0.160
Why?
Cyclophosphamide
4
2023
266
0.160
Why?
Leukemia, B-Cell
1
2020
12
0.160
Why?
Mice, Inbred NOD
3
2019
610
0.160
Why?
Bacterial Toxins
1
2020
109
0.160
Why?
B-Lymphocytes
4
2018
876
0.150
Why?
Immunodominant Epitopes
2
2012
27
0.150
Why?
Clinical Studies as Topic
1
2019
12
0.150
Why?
Proto-Oncogene Proteins c-cbl
1
2019
13
0.150
Why?
Cell Proliferation
6
2024
2496
0.150
Why?
Histone-Lysine N-Methyltransferase
1
2021
141
0.150
Why?
Pediatrics
1
2008
1114
0.150
Why?
Interleukin-3 Receptor alpha Subunit
1
2019
17
0.150
Why?
Epitopes
2
2018
485
0.150
Why?
In Vitro Techniques
1
2020
1047
0.140
Why?
Cell Membrane
2
2020
706
0.140
Why?
Immunomodulation
1
2019
101
0.140
Why?
History, 21st Century
1
2019
219
0.140
Why?
Immunologic Factors
1
2020
255
0.140
Why?
Multiple Myeloma
1
2021
291
0.140
Why?
Cryopreservation
1
2019
110
0.140
Why?
Cell- and Tissue-Based Therapy
2
2018
80
0.140
Why?
History, 20th Century
1
2019
325
0.140
Why?
Autoantigens
2
2019
429
0.140
Why?
Membrane Proteins
1
2004
1166
0.130
Why?
Graft Survival
3
2011
526
0.130
Why?
Cell Division
3
2012
766
0.130
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2012
1953
0.130
Why?
Secondary Prevention
1
2019
254
0.130
Why?
Follow-Up Studies
5
2021
5408
0.130
Why?
Down Syndrome
1
2024
534
0.130
Why?
Fas Ligand Protein
2
2019
60
0.130
Why?
Inflammation Mediators
1
2020
509
0.130
Why?
Salvage Therapy
2
2023
162
0.130
Why?
Tumor Microenvironment
2
2019
732
0.130
Why?
Chromatin
2
2023
561
0.130
Why?
Immunophenotyping
2
2020
322
0.130
Why?
Cell Engineering
1
2017
14
0.130
Why?
Spine
1
2018
182
0.120
Why?
Cell Culture Techniques
1
2019
375
0.120
Why?
Lymph Nodes
3
2013
502
0.120
Why?
Cytomegalovirus Infections
1
2018
206
0.120
Why?
Stem Cell Research
1
2016
1
0.120
Why?
CD4 Lymphocyte Count
4
2008
277
0.120
Why?
Receptors, Calcium-Sensing
1
2015
6
0.120
Why?
Stem Cell Niche
1
2016
58
0.120
Why?
Clone Cells
1
2016
266
0.120
Why?
Retrospective Studies
9
2023
17066
0.120
Why?
PAX5 Transcription Factor
1
2015
14
0.120
Why?
Infant
8
2018
10034
0.120
Why?
Antineoplastic Agents
3
2019
2194
0.110
Why?
Janus Kinases
1
2015
20
0.110
Why?
STAT Transcription Factors
1
2015
24
0.110
Why?
Transcription Factors
1
2023
1741
0.110
Why?
Receptor Protein-Tyrosine Kinases
1
2017
230
0.110
Why?
Lymphoma, Large B-Cell, Diffuse
1
2018
192
0.110
Why?
Gene Editing
1
2016
93
0.110
Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
1
2015
23
0.110
Why?
Myeloid Cells
1
2016
148
0.110
Why?
Cell Line
2
2017
2882
0.110
Why?
Receptors, Cell Surface
1
2017
377
0.110
Why?
4-1BB Ligand
1
2014
7
0.110
Why?
Prospective Studies
5
2023
7990
0.110
Why?
Aging
3
2002
1966
0.110
Why?
Calgranulin B
1
2014
10
0.110
Why?
Growth
1
1994
49
0.110
Why?
Calgranulin A
1
2014
11
0.110
Why?
Virus Replication
1
2017
529
0.110
Why?
Mice, 129 Strain
1
2014
86
0.110
Why?
Models, Biological
3
2009
1821
0.100
Why?
Survival Analysis
2
2017
1382
0.100
Why?
Growth Disorders
1
1994
86
0.100
Why?
Gastrointestinal Neoplasms
1
2014
70
0.100
Why?
Attitude to Health
2
2008
436
0.100
Why?
Mice, Inbred BALB C
2
2021
1253
0.100
Why?
Genome
1
2016
306
0.100
Why?
Phenotype
4
2019
3162
0.100
Why?
Erythrocytes
1
2020
757
0.100
Why?
Recombinant Proteins
6
2011
1370
0.100
Why?
Body Height
1
1994
202
0.100
Why?
Transduction, Genetic
3
2019
133
0.100
Why?
fas Receptor
2
2019
92
0.100
Why?
Lymphoma, Non-Hodgkin
1
2014
124
0.100
Why?
T-Lymphocytes, Cytotoxic
1
2014
177
0.100
Why?
Alternative Splicing
1
2015
247
0.100
Why?
Incidence
2
2018
2879
0.100
Why?
Animals, Congenic
1
2012
9
0.100
Why?
Radiation Chimera
1
2012
27
0.100
Why?
Specific Pathogen-Free Organisms
1
2012
58
0.100
Why?
Proteins
1
2019
1021
0.100
Why?
CD3 Complex
3
2017
111
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2012
54
0.090
Why?
Minor Histocompatibility Antigens
1
2012
47
0.090
Why?
Treatment Failure
2
2014
365
0.090
Why?
Carcinoma, Transitional Cell
1
2012
68
0.090
Why?
Tumor Burden
1
2013
319
0.090
Why?
Chemokines
1
2013
218
0.090
Why?
Antigen-Presenting Cells
2
2010
160
0.090
Why?
Tissue and Organ Procurement
1
2016
346
0.090
Why?
Body Weight
2
2002
976
0.090
Why?
Blood Component Removal
1
2011
28
0.090
Why?
CD28 Antigens
2
2025
58
0.090
Why?
Interleukin-6
1
2015
780
0.090
Why?
CD4-CD8 Ratio
2
2019
23
0.090
Why?
Epigenesis, Genetic
1
2016
684
0.090
Why?
Methoxsalen
1
2011
4
0.080
Why?
Adenovirus Infections, Human
1
2010
15
0.080
Why?
Spleen
2
2011
508
0.080
Why?
Brain Neoplasms
2
2011
1318
0.080
Why?
Cytosine
1
2010
51
0.080
Why?
Blood
1
2011
109
0.080
Why?
Alleles
1
2013
879
0.080
Why?
Antiretroviral Therapy, Highly Active
2
2002
278
0.080
Why?
Organophosphonates
1
2010
97
0.080
Why?
Hematopoiesis
3
2016
194
0.080
Why?
Antiviral Agents
2
2018
767
0.080
Why?
Transplantation Immunology
1
2009
29
0.080
Why?
Ophthalmoplegia
1
1989
13
0.080
Why?
Acute Disease
3
2023
1030
0.080
Why?
Paranasal Sinus Neoplasms
1
1989
29
0.070
Why?
Laryngeal Neoplasms
1
1989
35
0.070
Why?
Intestinal Neoplasms
1
2009
30
0.070
Why?
Sarcoma
1
2011
205
0.070
Why?
Hematopoietic System
1
2008
7
0.070
Why?
Virus Diseases
1
2011
216
0.070
Why?
Interleukin-12
1
2009
117
0.070
Why?
Sibling Relations
1
2008
10
0.070
Why?
Substrate Specificity
1
2009
388
0.070
Why?
Cell Differentiation
4
2023
2050
0.070
Why?
National Cancer Institute (U.S.)
1
2008
52
0.070
Why?
Ultraviolet Rays
1
2011
388
0.070
Why?
Lymphocyte Subsets
2
2014
83
0.070
Why?
Psychology
1
2008
88
0.060
Why?
Skin Neoplasms
1
2014
847
0.060
Why?
Cells, Cultured
2
2014
4154
0.060
Why?
Tumor Cells, Cultured
1
2009
919
0.060
Why?
Lipopolysaccharides
1
2011
863
0.060
Why?
Middle Aged
9
2025
35875
0.060
Why?
Biomarkers
2
2016
4271
0.060
Why?
Macaca fascicularis
2
2007
71
0.060
Why?
Immune Tolerance
2
2010
379
0.060
Why?
Chemokine CCL4
1
2026
31
0.060
Why?
Aged
7
2025
25913
0.060
Why?
Ki-67 Antigen
2
2004
117
0.060
Why?
Brain
1
2018
2933
0.060
Why?
Proto-Oncogene Proteins c-bcl-2
2
2008
240
0.060
Why?
Polymerase Chain Reaction
2
2022
1054
0.050
Why?
Immunologic Surveillance
1
2004
25
0.050
Why?
Carcinoma, Squamous Cell
1
1989
641
0.050
Why?
Hemostasis
1
2004
102
0.050
Why?
Nitriles
1
2024
205
0.050
Why?
United States
4
2018
15966
0.050
Why?
p38 Mitogen-Activated Protein Kinases
1
2024
266
0.050
Why?
Obesity
2
2022
3077
0.050
Why?
CD47 Antigen
1
2023
42
0.050
Why?
Autoimmune Diseases
1
2006
463
0.040
Why?
Gene Rearrangement, T-Lymphocyte
1
2002
16
0.040
Why?
Histocompatibility Testing
2
2014
121
0.040
Why?
Real-Time Polymerase Chain Reaction
1
2022
341
0.040
Why?
DNA Copy Number Variations
1
2022
183
0.040
Why?
Cohort Studies
3
2014
5960
0.040
Why?
United Kingdom
2
2009
338
0.040
Why?
Thymectomy
1
2001
15
0.040
Why?
Body Mass Index
1
2009
2438
0.040
Why?
Pyrimidines
1
2024
532
0.040
Why?
HIV Protease Inhibitors
1
2001
69
0.040
Why?
Pyrazoles
1
2024
509
0.040
Why?
Ritonavir
1
2001
75
0.040
Why?
Skin Transplantation
1
2001
85
0.040
Why?
Cell Survival
2
2019
1098
0.040
Why?
NF-kappa B
1
2024
661
0.040
Why?
Peptides
1
2026
995
0.040
Why?
Lymphocytes
1
2002
382
0.040
Why?
Fatal Outcome
1
2020
307
0.040
Why?
Subcutaneous Emphysema
1
1999
1
0.040
Why?
Fas-Associated Death Domain Protein
1
2019
9
0.040
Why?
Mice, Nude
1
2001
682
0.040
Why?
Vulva
1
1999
23
0.040
Why?
Proto-Oncogene Proteins
1
2002
623
0.040
Why?
Single-Chain Antibodies
1
2019
15
0.040
Why?
Up-Regulation
3
2008
851
0.040
Why?
K562 Cells
1
2019
93
0.040
Why?
Postoperative Complications
1
2011
2919
0.040
Why?
Immunization
1
2001
374
0.040
Why?
Pneumatosis Cystoides Intestinalis
1
1999
21
0.040
Why?
Age Factors
3
2011
3333
0.040
Why?
Guidelines as Topic
1
2020
267
0.040
Why?
Transgenes
1
2019
189
0.040
Why?
Mental Status and Dementia Tests
1
2018
26
0.040
Why?
Hallucinations
1
2018
31
0.040
Why?
Confusion
1
2018
30
0.040
Why?
Cancer Care Facilities
1
2018
48
0.030
Why?
Epitopes, T-Lymphocyte
1
2019
175
0.030
Why?
National Institutes of Health (U.S.)
1
2018
140
0.030
Why?
Steroids
1
2018
160
0.030
Why?
Risk Factors
4
2018
10779
0.030
Why?
Positron-Emission Tomography
1
2019
323
0.030
Why?
Gene Order
1
2017
27
0.030
Why?
Graft Rejection
1
2001
540
0.030
Why?
Interdisciplinary Communication
1
2018
197
0.030
Why?
Molecular Targeted Therapy
1
2020
432
0.030
Why?
Advisory Committees
1
2018
228
0.030
Why?
Transfection
1
2019
940
0.030
Why?
Weight Loss
1
2002
836
0.030
Why?
HEK293 Cells
1
2019
744
0.030
Why?
Disease-Free Survival
1
2018
769
0.030
Why?
Cell Cycle
1
2019
596
0.030
Why?
Research Subjects
1
2016
41
0.030
Why?
Protein Engineering
1
2017
122
0.030
Why?
Ethics Committees, Research
1
2016
41
0.030
Why?
Time Factors
4
2008
7173
0.030
Why?
Cell Adhesion
1
2017
455
0.030
Why?
Serine-Arginine Splicing Factors
1
2015
26
0.030
Why?
Medical Oncology
1
2018
332
0.030
Why?
Genetic Therapy
1
2017
313
0.030
Why?
Health Policy
1
2018
400
0.030
Why?
Surveys and Questionnaires
1
2008
6048
0.030
Why?
Anti-HIV Agents
1
2002
888
0.030
Why?
Transplantation Chimera
1
2014
56
0.030
Why?
Chimera
1
2014
61
0.030
Why?
Infant, Newborn
2
2018
6429
0.030
Why?
Exons
1
2015
358
0.030
Why?
Reproducibility of Results
1
2022
3409
0.030
Why?
Societies, Medical
1
2018
887
0.030
Why?
Interleukin-2
1
2015
437
0.030
Why?
Neoplasm Transplantation
1
2014
251
0.030
Why?
Longitudinal Studies
1
2001
2947
0.020
Why?
Reference Values
1
1994
797
0.020
Why?
Lung
1
2026
4109
0.020
Why?
Transcriptome
1
2019
1045
0.020
Why?
Sequence Analysis, DNA
1
2015
824
0.020
Why?
Neoplastic Stem Cells
1
2016
412
0.020
Why?
Vidarabine
1
2012
32
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
97
0.020
Why?
Colonic Neoplasms
1
2014
259
0.020
Why?
Etoposide
1
2012
166
0.020
Why?
RNA-Binding Proteins
1
2015
462
0.020
Why?
Administration, Oral
1
2014
847
0.020
Why?
Vincristine
1
2012
140
0.020
Why?
Prednisone
1
2012
221
0.020
Why?
Rituximab
1
2012
209
0.020
Why?
Feasibility Studies
1
2014
1095
0.020
Why?
Body Fat Distribution
1
2009
45
0.020
Why?
Doxorubicin
1
2012
397
0.020
Why?
Bone Neoplasms
1
2012
253
0.020
Why?
Opportunistic Infections
1
2009
45
0.020
Why?
Biomedical Research
1
2016
710
0.020
Why?
Bacteremia
1
2011
221
0.020
Why?
Transcription, Genetic
1
2015
1496
0.020
Why?
Kaplan-Meier Estimate
1
2011
965
0.020
Why?
Risk
1
2011
911
0.020
Why?
CD8 Antigens
1
2008
72
0.020
Why?
Lymphatic Metastasis
1
1989
333
0.020
Why?
Leukocytes
1
2010
295
0.020
Why?
Cell Separation
1
2008
307
0.020
Why?
HLA Antigens
1
2008
225
0.020
Why?
RNA, Messenger
1
2015
2832
0.020
Why?
HIV
1
2008
250
0.020
Why?
Cell Polarity
1
2007
137
0.010
Why?
Mass Screening
1
1994
1347
0.010
Why?
Magnetic Resonance Imaging
1
2018
3863
0.010
Why?
Body Composition
1
2009
706
0.010
Why?
Forkhead Transcription Factors
1
2006
202
0.010
Why?
Catheter Ablation
1
2009
353
0.010
Why?
Adiposity
1
2009
543
0.010
Why?
Bone Marrow Cells
1
2006
320
0.010
Why?
Interleukins
1
2006
248
0.010
Why?
Annexin A5
1
2004
21
0.010
Why?
Tomography, X-Ray Computed
2
1999
2730
0.010
Why?
Coloring Agents
1
2004
93
0.010
Why?
Stromal Cells
1
2004
124
0.010
Why?
Macaca mulatta
1
2004
191
0.010
Why?
Immunosuppressive Agents
1
2008
846
0.010
Why?
Tissue Distribution
1
2004
327
0.010
Why?
Sensitivity and Specificity
1
2008
1985
0.010
Why?
Predictive Value of Tests
1
2008
2115
0.010
Why?
Immunity, Innate
1
2009
846
0.010
Why?
bcl-2-Associated X Protein
1
2002
54
0.010
Why?
Models, Genetic
1
2004
536
0.010
Why?
Transplantation, Isogeneic
1
2001
17
0.010
Why?
Temperature
1
2004
679
0.010
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
331
0.010
Why?
Leukocyte Common Antigens
1
2001
88
0.010
Why?
Kinetics
1
2004
1627
0.010
Why?
Colon
1
2002
304
0.010
Why?
Tumor Necrosis Factor-alpha
1
2004
1217
0.010
Why?
Pubic Bone
1
1999
6
0.010
Why?
Genotype
1
2004
1833
0.010
Why?
Hyperbaric Oxygenation
1
1999
39
0.010
Why?
Risk Assessment
1
2008
3671
0.010
Why?
Radiography, Abdominal
1
1999
44
0.010
Why?
Cardiovascular Diseases
1
2009
2168
0.010
Why?
Antibodies, Monoclonal
1
2004
1519
0.010
Why?
Cross-Sectional Studies
1
2007
5868
0.010
Why?
Liver
1
2002
1887
0.010
Why?
Fry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)